Catalyst Wire Dossier Catalyst Wire Dossier

R932348

· Rigel Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R932348, covering 2016-10-10 to 2016-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2) [Phase 2]

See pricing